Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
7.35
+0.53 (7.77%)
At close: Sep 16, 2025, 4:00 PM EDT
7.44
+0.09 (1.22%)
After-hours: Sep 16, 2025, 6:35 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $817.76 million as of September 16, 2025. Its market cap has decreased by -32.70% in one year.
Market Cap
817.76M
Enterprise Value
671.99M
1-Year Change
-32.70%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $817.76M, an increase of 423.18%. That is a compound annual growth rate of 45.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 758.79M | 128.61% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |